MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 2014 May 07;14(1):22
Date
01/23/2015Pubmed ID
25608570Pubmed Central ID
PMC4331827DOI
10.1186/1470-7330-14-22Scopus ID
2-s2.0-84941202612 (requires institutional sign-in at Scopus site) 85 CitationsAbstract
We aimed to characterize specific MRI findings seen in immune competent patients with intracranial primary CNS lymphoma (PCNSL) and to determine their value in the management of such patients. Pre-treatment MRI examinations of 21 immunocompetent patients with biopsy-proven PCNSL were retrospectively evaluated. T1 and T2 signal characteristics as well as contrast enhancement features are described in all patients. Diffusion, perfusion and proton-MR-spectroscopy features are described in a subset of these patients. In the proper clinical and radiologic setting, suggesting the diagnosis of PCNSL can help institute proper treatment in a timely fashion and avoid unnecessary attempts at surgical resection and the associated morbidity.
Author List
Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HAAuthor
Monther Qandeel MBChB Assistant Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Brain Neoplasms
Diffusion Magnetic Resonance Imaging
Female
Humans
Lymphoma
Magnetic Resonance Imaging
Male
Middle Aged
Retrospective Studies









